Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of BAY 59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients
This study has been completed.
Study NCT00044525   Information provided by Bayer
First Received: August 30, 2002   Last Updated: May 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Neoplasms
Metastases, Neoplasm
Additional conditions recognized in this trial
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Skin Diseases
Interventions listed in this trial
BAY59-8862 (Cytotoxic Taxane)
Additional drug interventions recognized in this trial
Taxane
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services